ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001652044 Also files as an issuer

Alphabet Inc.

CIK 0001652044 Name as filed on the most recent filing

Filed as Alphabet Inc. (59)

312 transaction lines · from 59 filings · filed 2019-06-18 to 2026-07-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2023-05-11 Prime Medicine, Inc.
PRME 		S, Open-market sale 4,807 disposed 13.79 66,289.97 Form 4, filing 0001209191-23-029033
2023-05-10 Prime Medicine, Inc.
PRME 		S, Open-market sale 87,397 disposed 14.03 1,225,804.10 Form 4, filing 0001209191-23-029033
2023-05-09 Prime Medicine, Inc.
PRME 		S, Open-market sale 321,238 disposed 14.08 4,522,613.43 Form 4, filing 0001209191-23-028464
2023-05-08 Prime Medicine, Inc.
PRME 		S, Open-market sale 100,772 disposed 14.13 1,423,726.97 Form 4, filing 0001209191-23-028464
2023-05-05 Gitlab Inc.
GTLB 		P, Open-market purchase 7,286 acquired 26.98 196,583.57 Form 4, filing 0001209191-23-028245
2023-05-04 Gitlab Inc.
GTLB 		P, Open-market purchase 302,483 acquired 26.75 8,092,418.44 Form 4, filing 0001209191-23-027711
2023-05-04 Gitlab Inc.
GTLB 		P, Open-market purchase 91,710 acquired 27.65 2,535,983.26 Form 4, filing 0001209191-23-027711
2023-05-04 Gitlab Inc.
GTLB 		P, Open-market purchase 2,168 acquired 28.26 61,263.34 Form 4, filing 0001209191-23-027711
2023-05-03 Gitlab Inc.
GTLB 		P, Open-market purchase 287,470 acquired 28.30 8,134,021.14 Form 4, filing 0001209191-23-027711
2023-05-03 Gitlab Inc.
GTLB 		P, Open-market purchase 22,461 acquired 28.95 650,306.59 Form 4, filing 0001209191-23-027711
2023-03-14 Gitlab Inc.
GTLB 		P, Open-market purchase 169,156 acquired 30.30 5,125,934.27 Form 4, filing 0001209191-23-018969
2023-03-14 Gitlab Inc.
GTLB 		P, Open-market purchase 55,051 acquired 30.97 1,704,808.36 Form 4, filing 0001209191-23-018969
2023-03-13 Gitlab Inc.
GTLB 		P, Open-market purchase 152,251 acquired 29.12 4,433,244.62 Form 4, filing 0001209191-23-018969
2023-03-13 Gitlab Inc.
GTLB 		P, Open-market purchase 126,938 acquired 30.27 3,842,908.32 Form 4, filing 0001209191-23-018969
2023-03-13 Gitlab Inc.
GTLB 		P, Open-market purchase 119,798 acquired 28.26 3,384,940.41 Form 4, filing 0001209191-23-018969
2023-03-13 Gitlab Inc.
GTLB 		P, Open-market purchase 16,013 acquired 30.99 496,310.12 Form 4, filing 0001209191-23-018969
2022-11-09 Gitlab Inc.
GTLB 		P, Open-market purchase 128,911 acquired 34.29 4,420,757.81 Form 4, filing 0001209191-22-056458
2022-11-09 Gitlab Inc.
GTLB 		P, Open-market purchase 42,833 acquired 35.15 1,505,614.22 Form 4, filing 0001209191-22-056458
2022-11-09 Gitlab Inc.
GTLB 		P, Open-market purchase 10,568 acquired 36.09 381,440.34 Form 4, filing 0001209191-22-056458
2022-11-08 Gitlab Inc.
GTLB 		P, Open-market purchase 25,159 acquired 36.38 915,163.66 Form 4, filing 0001209191-22-056458
2022-11-08 Gitlab Inc.
GTLB 		P, Open-market purchase 14,264 acquired 35.97 513,023.30 Form 4, filing 0001209191-22-056458
2022-11-07 Gitlab Inc.
GTLB 		P, Open-market purchase 136,376 acquired 34.91 4,760,286.11 Form 4, filing 0001209191-22-056129
2022-11-07 Gitlab Inc.
GTLB 		P, Open-market purchase 65,421 acquired 35.69 2,334,875.49 Form 4, filing 0001209191-22-056129
2022-11-07 Gitlab Inc.
GTLB 		P, Open-market purchase 100 acquired 36.41 3,641.00 Form 4, filing 0001209191-22-056129
2022-11-04 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 47,690 disposed 31.12 1,484,017.42 Form 4, filing 0001209191-22-056122
2022-11-04 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 47,690 disposed 31.12 1,484,017.42 Form 4, filing 0001209191-22-056122
2022-11-04 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 651 disposed 31.99 20,825.82 Form 4, filing 0001209191-22-056122
2022-11-04 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 650 disposed 31.99 20,793.82 Form 4, filing 0001209191-22-056122
2022-11-04 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 243 disposed 32.90 7,994.70 Form 4, filing 0001209191-22-056122
2022-11-04 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 242 disposed 32.90 7,961.80 Form 4, filing 0001209191-22-056122
2022-11-04 Gitlab Inc.
GTLB 		P, Open-market purchase 141,028 acquired 36.29 5,117,892.02 Form 4, filing 0001209191-22-056129
2022-11-04 Gitlab Inc.
GTLB 		P, Open-market purchase 121,424 acquired 35.53 4,313,672.60 Form 4, filing 0001209191-22-056129
2022-11-04 Gitlab Inc.
GTLB 		P, Open-market purchase 15,041 acquired 37.21 559,692.16 Form 4, filing 0001209191-22-056129
2022-11-03 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 25,535 disposed 33.14 846,189.04 Form 4, filing 0001209191-22-055791
2022-11-03 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 25,534 disposed 33.14 846,155.91 Form 4, filing 0001209191-22-055791
2022-11-03 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 22,279 disposed 32.32 719,957.02 Form 4, filing 0001209191-22-055791
2022-11-03 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 22,279 disposed 32.32 719,957.02 Form 4, filing 0001209191-22-055791
2022-11-03 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 1,755 disposed 33.84 59,384.46 Form 4, filing 0001209191-22-055791
2022-11-03 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 1,755 disposed 33.84 59,384.46 Form 4, filing 0001209191-22-055791
2022-11-02 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 10,372 disposed 36.28 376,281.64 Form 4, filing 0001209191-22-055791
2022-11-02 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 10,372 disposed 36.28 376,281.64 Form 4, filing 0001209191-22-055791
2022-11-02 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 9,350 disposed 34.78 325,149.99 Form 4, filing 0001209191-22-055791
2022-11-02 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 9,349 disposed 34.78 325,115.21 Form 4, filing 0001209191-22-055791
2022-11-02 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 8,930 disposed 36.78 328,400.75 Form 4, filing 0001209191-22-055791
2022-11-02 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 8,930 disposed 36.78 328,400.75 Form 4, filing 0001209191-22-055791
2022-11-01 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 29,326 disposed 36.69 1,075,906.42 Form 4, filing 0001209191-22-055288
2022-11-01 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 29,326 disposed 36.69 1,075,906.42 Form 4, filing 0001209191-22-055288
2022-11-01 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 2,377 disposed 37.82 89,900.52 Form 4, filing 0001209191-22-055288
2022-11-01 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 2,377 disposed 37.82 89,900.52 Form 4, filing 0001209191-22-055288
2022-11-01 Verve Therapeutics, Inc.
VERV 		S, Open-market sale 260 disposed 38.64 10,046.01 Form 4, filing 0001209191-22-055288

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Alphabet Inc., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001652044

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.